SOCS3 and breast carcinoma: Hypermethylation of promoter region of SOCS3 resulted in gene silencing implicated in cancer pathogenesis including hematological malignancies   35 , prostate cancer   36 , pancreatic cancer   37 , endometrial carcinoma   38 , hepatocellular carcinoma   39  and breast cancer        40 .